| 000 | 01475 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250512064622.0 | ||
| 264 | 0 | _c19880114 | |
| 008 | 198801s 0 0 eng d | ||
| 022 | _a0277-5379 | ||
| 024 | 7 |
_a10.1016/0277-5379(87)90129-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRouëssé, J G | |
| 245 | 0 | 0 |
_aPhase II study of 1,2,4-triglycidyl urasol (TGU) in advanced soft tissue sarcoma. A trial of the EORTC Soft Tissue and Bone Sarcoma Cooperative Group. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer & clinical oncology _cSep 1987 |
||
| 300 |
_a1413-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukopenia _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSarcoma _xdrug therapy |
| 650 | 0 | 4 |
_aSoft Tissue Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
| 650 | 0 | 4 |
_aTriazoles _xadverse effects |
| 700 | 1 | _avan Oosterom, A T | |
| 700 | 1 | _aCapellaere, P | |
| 700 | 1 | _aKerbrat, P | |
| 700 | 1 | _avan Coninge, C J | |
| 700 | 1 | _aThomas, D | |
| 700 | 1 | _aBenshahar, D | |
| 773 | 0 |
_tEuropean journal of cancer & clinical oncology _gvol. 23 _gno. 9 _gp. 1413-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0277-5379(87)90129-5 _zAvailable from publisher's website |
| 999 |
_c3684029 _d3684029 |
||